Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report
2013; Elsevier BV; Volume: 122; Issue: 8 Linguagem: Inglês
10.1182/blood-2013-03-488098
ISSN1528-0020
AutoresAyalew Tefferi, Francisco Cervantes, Ruben A. Mesa, Francesco Passamonti, Srđan Verstovšek, Alessandro M. Vannucchi, Jason Gotlib, Brigitte Dupriez, Animesh Pardanani, Claire Harrison, Ronald Hoffman, Heinz Gisslinger, Nicolaus Kröger, Jüergen Thiele, Tiziano Barbui, Giovanni Barosi,
Tópico(s)Kruppel-like factors research
ResumoKey Points Treatment response criteria for MF must capture drug benefit in terms of symptom burden. The current document includes stricter definitions of red cell transfusion need and independence.
Referência(s)